AACR treatment of bladder cancer, bicyclic peptide conjugate therapy achieves 50% objective response rate
Time of Update: 2022-06-18
▲Characteristic comparison of bicyclic peptides with small molecules and antibodies (Image source: Bicycle Therapeutics' official website) In this clinical trial, patients with solid tumors who had received an average of 3 previous treatments received different doses of BT8009, of which 49% for urothelial carcinoma patients .
Nearly $1 billion
Time of Update: 2022-01-25
January 13, 2022 / eMedClub News / -- Acadia Pharmaceuticals and Stoke Therapeutics recently announced that the two companies have entered into a nearly $1 billion collaboration to jointly discover, develop and commercialize novel RNA-based medicines, For the treatment of severe and rare inherited neurodevelopmental disorders of the central nervous system (CNS) .
"Double Pound" breakthrough clinical research results released, providing new options for diabetes treatment
Time of Update: 2021-09-03
In addition, in terms of treatment burden, daily life, diabetes management , patient compliance, mental health, and treatment effect, patients who manage iGlarLixi report better outcomes than premixed insulin iv iv .
The collection policy to promote three years of multi-differentiation shows what kind of bureau the local leading pharmaceutical companies
Time of Update: 2020-11-02
And at the specific product level, in the first half of this year, the State Drug Administration approved a total of 212 drug batches, involving 146 varieties, Qilu Pharmaceuticals became the biggest winner, a total of 9 generic drug varieties were approved for listing, ranking first, followed by China Biopharmaceuticals, Huahai Pharmaceuticals, Colum Pharmaceuticals and other local giants.
Well-known pharmaceutical companies bought six large varieties
Time of Update: 2020-10-04
The sales data of these varieties are as follows (some companies can not learn the relevant data from public sources): FangSheng Pharmaceuticals said in the announcement, the company to "drug market licensing holder system" as an opportunity to actively reserve drug varieties with potential for development, enrich the company's product line, is conducive to promoting industrial chain integration and industrial expansion, promote the company to become bigger and stronger quickly.
State Drug Administration: Medical ID card landing enterprise inspection began
Time of Update: 2020-08-27
gradually establish and improve the drug information traceability mechanism, to achieve vaccines and national organizations to focus on the procurement and use of drugs "one thing, one yard", select some high-value medical supplies and other key varieties to implement the unique identification of medical devices.
Sci Rep: Watch out! People who are pessimistic about their future performance have a higher risk of premature death
Time of Update: 2020-08-06
Aug 3, 2020 // In a recent study published in the international journal Scientific Reports, scientists from the QIMR Berghofer Institute of Medicine found that people who are extremely pessimistic abo
At present, what are the treatment methods of psoriasis and rheumatoid arthritis
Time of Update: 2020-01-22
Psoriasis, also known as psoriasis, is a kind of recurrent and stubborn skin disease, and psoriatic arthritis not only leads to plaque lesions on the skin surface of patients, but also leads to joint
The first application of McAb for the treatment of hereditary angioedema in China
Time of Update: 2019-04-01
Sina medicine was inquired by the official website of the National Drug Examination Center (CDE) and learned that lanadelumab, the first McAb for the treatment of hereditary angioedema (HAE), applied